Number of Volunteers Enrolled, Vaccination Schedule, Sample Collection and Assessment Time Points.

a

(N/n) Number of vaccine recipients/number of placebo recipients per group.

b

Vaccines/Dosage Groups: - rAd5: VRC HIV-1 rAd5 at 1×1010 or 1×1011 PU - 3DNA: 3 doses of VRC HIV-1 DNA at 4 mg/dose given intramuscularly by needle-free injection using Biojector ® 2000.

↓indicates vaccination visit.

S: Sample collection and assessment time points (S):

c

Serum neutralizing antibodies against Ad5.

d

Vaccine-induced HIV-1 specific cellular immune responses.

e

Vaccine-induced HIV-1 specific humoral immune responses.

Categories

Keyword(s)

License

CC BY 4.0